1. Alba SF, Skouras DB, Dinarello CA, López-Vales R. OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis. Front Immunol 2019; 10: 492466.
2.
Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR. IL-1b regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program.
3.
J Immunol 2006; 177: 5574-5584.
4.
Arsalan H, Zhang W, Shagufta P, Arshad M. The association between comorbid body dysmorphic disorder and depression: moderation effect of age and mediation effect of body mass index and body image among Pakistani students. Middle East Current Psy 2023; 30: 11.
5.
Cardone J, Le Friec G, Vantourout P, Roberts A, Fuchs A, Jackson I, Suddason T, Lord G, Atkinson JP, Cope A, Hayday A, Kemper C. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat Immunol 2010; 11: 862-871.
6.
Carrì MT, Valle C, Bozzo F, Cozzolino M. Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Front Cell Neurosci 2015; 9: 41.
7.
Casati A, Frascoli M, Traggiai E, Proietti M, Schenk U, Grassi F. Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP. Cell Death Differ 2011; 18: 396-404.
8.
Dinarello CA, Simon A, van der Meer JMW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 2012; 11: 633-652.
9.
Duhen R, Glatigny S, Arbelaez CA, Blair TC, Oukka M, Bettelli E. Cutting edge: The pathogenicity of IFN-g-producing Th17 cells is independent of T-bet. J Immunol 2013; 190: 4478-4482.
10.
Eyo UB, Wu LJ. Microglia: Lifelong patrolling immune cells of the brain. Prog Neurobiol 2019; 179: 101614.
11.
Gómez-Virgilio L, Silva-Lucero MD, Flores-Morelos DS, Gallardo-Nieto J, Lopez-Toledo G, Abarca-Fernandez AM, Zacapala-
12.
Gómez AE, Luna-Muñoz J, Montiel-Sosa F, Soto-Rojas LO, Pacheco-Herrero M, Cardenas-Aguayo MD. Autophagy: A key regulator of homeostasis and disease: An overview of molecular mechanisms and modulators. Cells 2022; 11: 2262.
13.
Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, Huang M, Schneider M, Miller SD, Ting JPY. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol 2010; 185: 974-981.
14.
Heidary M, Rakhshi N, Kakhki MP, Behmanesh M, Sanati MH, Sanadgol N, Kamaladini H, Nikravesh A. The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients. J Neurol Sci 2014; 343: 41-45.
15.
Hewett SJ, Jackman NA, Claycomb RJ. Interleukin 1b in central nervous system injury and repair. Eur J Neurodegener Dis 2012; 1: 195.
16.
Jones A, Hawiger D. Peripherally induced regulatory T cells: recruited protectors of the central nervous system against autoimmune neuroinflammation. Front Immunol 2017; 8: 269169.
17.
Lalor SJ, Dungan LS, Sutton CE, Basdeo SA, Fletcher JM, Mills KHG. Caspase-1-processed cytokines IL-1b and IL-18 promote IL-17 production by gd and CD4 T cells that mediate autoimmunity. J Immunol 2011; 186: 5738-5748.
18.
Lautrup S, Sinclair DA, Mattson MP, Fang EF. NAD+ in brain aging and neurodegenerative disorders. Cell Metab 2019; 30: 630-655.
19.
Lobsiger CS, Cleveland DW. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 2007; 10: 1355-1360.
20.
Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-b. Mol Cell 2002; 10: 417-426.
21.
Mehmood A, Ali W, Song S, Ud Din Z, Guo RY, Shah W, Ilahi I, Yin B, Yan H, Zhang L, Khan M, Ali W, Zeb L, Safari H, Li B. Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis. Brain Behav 2021; 11: e2302.
22.
Mehmood A, Ali W, Ud Din Z, Song S, Sohail M, Shah W, Guo J, Guo RY, Ilahi I, Shah S, Al-Shaebi F, Zeb L, Asiamah EA, Al-Dhamin Z, Bilal H, Li B. Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson’s disease. Brain Behav 2021; 11: e2280.
23.
Mehmood A, Shah S, Guo RY, Haider A, Shi M, Ali H, Ali I, Ullah R, Li B. Methyl-CpG-binding protein 2 emerges as a central player in multiple sclerosis and neuromyelitis optica spectrum disorders. Cell Mol Neurobiol 2023; 43: 4071-4101.
24.
Mehmood A, Song S, Du X, Yan H, Wang X, Guo L, Li B. mRNA expression profile reveals differentially expressed genes in splenocytes of experimental autoimmune encephalomyelitis model. Int J Exp Pathol 2023; 104: 247-257.
25.
Mokhtari T, Uludag K. Role of NLRP3 inflammasome in post-spinal-cord-injury anxiety and depression: Molecular mechanisms and therapeutic implications. ACS Chem Neurosci 2024; 15: 56-70.
26.
Pawlak M, Ho AW, Kuchroo VK. Cytokines and transcription factors in the differentiation of CD4+ T helper cell subsets and induction of tissue inflammation and autoimmunity. Curr Opin Immunol 2020; 67: 57-67.
27.
Perry VH, Teeling J. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol 2013; 35: 601-612.
28.
Pyka-Fościak G, Litwin JA, Lis GJ. Osteopontin expression and the effect of anti-VLA-4 mAb treatment in experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Folia Neuropathol 2023; 61: 129-137.
29.
Rangaraju S, Verrier JD, Madorsky I, Nicks J, Dunn WA Jr, Notterpek L. Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice. J Neurosci 2010; 30: 11388-11397.
30.
Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, Weiss S, Battistini L, Martino G, Furlan R, Drulovic J, Centonze D. Interleukin-1b causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Mol Neurodegener 2014; 9: 56.
31.
Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, Matsunaga K, Kageyama S, Omori H, Noda T, Yamamoto N, Kawai T, Ishii K, Takeuchi O, Yoshimori T, Akira S. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci U S A 2009; 106: 20842-20846.
32.
Sato K, Miyoshi F, Yokota K, Araki Y, Asanuma Y, Akiyama Y, Yoh K, Takahashi S, Aburatani H, Mimura T. Marked induction of c-Maf protein during Th17 cell differentiation and its implication in memory Th cell development. J Biol Chem 2011; 286: 14963-14971.
33.
Schuh E, Lohse P, Ertl-Wagner B, Witt M, Krumbholz M, Frankenberger M, Gerdes LA, Hohlfeld R, Kümpfel T. Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations. Neurol Neuroimmunol Neuroinflamm 2015; 2: e109.
34.
Schwarz N, Fliegert R, Adriouch S, Seman M, Guse AH, Haag F, Koch-Nolte F. Activation of the P2X7 ion channel by soluble and covalently bound ligands. Purinergic Signal 2009; 5: 139-149.
35.
Seman M, Adriouch S, Scheuplein F, Krebs C, Freese D, Glowacki G, Deterre P, Haag F, Koch-Nolte F. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 2003; 19: 571-582.
36.
Song S, Guo R, Mehmood A, Zhang L, Yin B, Yuan C, Zhang H, Guo L, Li B. Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway. CNS Neurosci Ther 2022; 28: 422-434.
37.
Suh SW, Hamby AM, Swanson RA. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007; 55: 1280-1286.
38.
Uludag K, Wang DM, Mohamoud Y, Wu HE, Zhang X. Antipsychotic-based machine learning models may help prediction of tardive dyskinesia in patients with schizophrenia. Schizophr Res 2023; 252: 33-35.
39.
Voskuhl RR, MacKenzie-Graham A. Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis. Front Mol Neurosci 2022; 15: 1024058.
40.
Wahid S, Imran A, Waniya S, Shoaib M, Ahmar I, Arshad M. Obesity prevalence factors associated with sympathetic overactivity and hypertension. Neurol Clin Neurosci 2023; 11: 310-315.
41.
Wang G, Jing L, Wang Y, Mehmood A, Zhang H, Guo R, Zhang L, Li B. Interferon regulatory factor 5 gene polymorphisms and mRNA expression levels are associated with neuromyelitis optica spectrum disorder. Mol Neurobiol 2024; 61: 7989-7999.
42.
Wang J, Wang J, Wang J, Yang B, Weng Q, He Q. Targeting microglia and macrophages: a potential treatment strategy for multiple sclerosis. Front Pharmacol 2019; 10: 440854.
43.
Wang J, Zhao C, Kong P, Sun H, Sun Z, Bian G, Sun Y, Guo L. Treatment with NAD+ inhibited experimental autoimmune encephalomyelitis by activating AMPK/SIRT1 signaling pathway and modulating Th1/Th17 immune responses in mice. Int Immunopharmacol 2016; 39: 287-294.
44.
Wang X, Li B, Liu L, Zhang L, Ma T, Guo L. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome. Int Immunopharmacol 2021; 90: 107092.
45.
Wang Y, Qin Z. Coordination of autophagy with other cellular activities. Acta Pharmacol Sin 2013; 34: 585-594.
46.
Yin BW, Li B, Mehmood A, Yuan C, Song S, Guo RY, Zhang L, Ma T, Guo L. BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder. CNS Neurosci Ther 2021; 27: 1549-1560.
47.
Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 2008; 10: 179-206.
48.
Yu J, Mu B, Guo M, Liu C, Meng T, Yan Y, Song L, Yu J, Kumar G, Ma C. Astragaloside IV inhibits experimental autoimmune encephalomyelitis by modulating the polarization of both microglia/macrophages and astrocytes. Folia Neuropathol 2023; 61: 273-290.
49.
Zeng X, Zhang K, Liang M, Yu B, Zhang P, Mehmood A, Zhang H. NAD+ affects differentially expressed genes-MBOAT2-SLC25A21-SOX6 in experimental autoimmune encephalomyelitis model. Int J Neurosci 2024; 1-8.
